Bioage labs to participate in td cowen's 45th annual health care conference

Richmond, calif., feb. 20, 2025 (globe newswire) -- bioage labs (nasdaq: bioa) (“bioage”, “the company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the company will participate in one-on-one meetings at td cowen's 45th annual health care conference.
COWN Ratings Summary
COWN Quant Ranking